This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (144)

Published on in Vol 6 , No 3 (2017) :March

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

Authors of this article:

Ian Gilron 1 Author Orcid Image ;   Dongsheng Tu 1 Author Orcid Image ;   Ronald Holden 1 Author Orcid Image ;   Tanveer Towheed 1 Author Orcid Image ;   Dan Ziegler 2 Author Orcid Image ;   Louie Wang 1 Author Orcid Image ;   Roumen Milev 1 Author Orcid Image ;   Christopher Gray 3 Author Orcid Image
Article Authors Cited by (5) Tweetations (4) Metrics

Ian Gilron   1 , MSc, FRCPC, MD ;   Dongsheng Tu   1 , PhD ;   Ronald Holden   1 , PhD ;   Tanveer Towheed   1 , FRCPC, MD ;   Dan Ziegler   2 , Prof Dr Med ;   Louie Wang   1 , MSc, FRCPC, MD ;   Roumen Milev   1 , FRCPC, MD, PhD ;   Christopher Gray   3 , CCRP

1 Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Kingston, ON, Canada

2 Heinrich Heine University, Dusseldorf, Germany

3 Kingston General Hospital, Kingston, ON, Canada

Corresponding Author: